| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 852,338 | $2,537,240 | $2.98 | 29 Aug 2024 | Direct |
| Aerovate Therapeutics, Inc. | Director | Common Stock | 86,215 | $229,331 | $2.66 | 28 Apr 2025 | Direct |
| Oruka Therapeutics, Inc. | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 230,000 | 22 Jan 2025 | Direct | ||
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 47,000 | 07 Jun 2023 | Direct | ||
| Aerovate Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 23,017 | 29 Apr 2025 | Direct | ||
| CRISPR Therapeutics AG | CBO & COO | Restricted Stock Units | 12,500 | 16 Aug 2022 | Direct | ||
| Dyne Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,222 | 05 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | 29 Apr 2025 | 1 | $0 | 4 | Director | 01 May 2025, 18:10 |
| JBIO | Jade Biosciences, Inc. | 28 Apr 2025 | 0 | $0 | 3 | Director | 01 May 2025, 17:44 |
| ORKA | Oruka Therapeutics, Inc. | 22 Jan 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 24 Jan 2025, 16:41 |
| ORKA | Oruka Therapeutics, Inc. | 29 Aug 2024 | 0 | $0 | 3 | President and CEO, Director | 06 Sep 2024, 17:00 |
| JSPR | Jasper Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:44 |
| JSPR | Jasper Therapeutics, Inc. | 12 Oct 2022 | 1 | $0 | 4 | Director | 13 Oct 2022, 20:07 |
| CRSP | CRISPR Therapeutics AG | 16 Aug 2022 | 1 | $0 | 4 | CBO & COO | 18 Aug 2022, 17:36 |
| DYN | Dyne Therapeutics, Inc. | 05 Jul 2022 | 1 | $0 | 4 | Director | 06 Jul 2022, 18:20 |
| DYN | Dyne Therapeutics, Inc. | 03 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 16:07 |
| JSPR | Jasper Therapeutics, Inc. | 21 Mar 2022 | 1 | $0 | 4 | Director | 23 Mar 2022, 18:05 |
| CRSP | CRISPR Therapeutics AG | 10 Mar 2022 | 6 | -$192,868 | 4 | CBO & COO | 14 Mar 2022, 18:03 |
| CRSP | CRISPR Therapeutics AG | 18 Feb 2022 | 2 | $0 | 4 | CBO & COO | 22 Feb 2022, 16:41 |
| CRSP | CRISPR Therapeutics AG | 03 Dec 2021 | 3 | -$773,666 | 4 | CBO & COO | 07 Dec 2021, 19:00 |
| CRSP | CRISPR Therapeutics AG | 15 Oct 2021 | 1 | $0 | 4 | CBO & COO | 18 Oct 2021, 20:00 |
| JSPR | Jasper Therapeutics, Inc. | 24 Sep 2021 | 0 | $0 | 3 | Director | 01 Oct 2021, 16:11 |
| CRSP | CRISPR Therapeutics AG | 10 Sep 2021 | 3 | -$495,837 | 4 | CBO & COO | 14 Sep 2021, 21:44 |
| DYN | Dyne Therapeutics, Inc. | 26 May 2021 | 1 | $0 | 4 | Director | 27 May 2021, 20:38 |